Wilk Technologies News
34 articles
Strauss Group (TASE:STRS): Assessing Valuation After Mixed Q2 Earnings and Sales Growth
Strauss Group has released its second quarter and half-year earnings, showing a rise in sales for both periods in 2025. Despite the increase in revenue, net income has decreased, indicating potential cost pressures or margin changes. The companys stock has risen by nearly 64% over the past year, though recent gains have slowed. Strauss Groups price-to-earnings ratio is slightly below the Asian Food industry average, suggesting it is valued in line with sector peers. The companys strong profit growth and above-average profit margin support its current valuation. However, potential risks include slowing net income growth or changes in consumer demand.
Nifty clocks fifth session of gains led by IT on Infosys buyback, US rate cut hopes
Infosys led gains in Indias Nifty 50 index, which closed higher for the fifth consecutive session, driven by a 5% surge in Infosys shares following the announcement of a share buyback plan. The IT sector, which accounted for a significant portion of the days gains, benefited from expectations of a U.S. interest rate cut, which could boost technology spending in the U.S., a key market for Indian IT firms. The broader market also saw gains, with the Nifty 50 and BSE Sensex both rising by 0.39%. The anticipation of a Federal Reserve rate cut was fueled by weaker-than-expected U.S. job data.
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
Nikkiso Clean Energy & Industrial Gases Group (Nikkiso CE&IG) announced the launch of a next-generation submerged ammonia pump at the Gastech Conference. This pump is designed to be the safest and most reliable in the industry, addressing common maintenance issues with its seal-less, maintenance-friendly, copper-free construction. The pump can deliver over 2,500m3 per hour and has a mean time between outages of over 16,000 hours. This launch is part of Nikkiso CE&IGs ongoing innovation in ammonia handling, with the company having decades of experience in this field. The pump is expected to meet growing demand for ammonia in various sectors, including power generation and shipping.
Product Stage
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
CAYIN Technology has partnered with Westin Desaru Coast Resort in Johor, Malaysia, to enhance guest communication and operational efficiency through the implementation of its CMS-WS server and CAYIN Signage Player. This collaboration involves the use of digital signage to provide real-time updates across 14 Samsung displays in various areas of the resort. The project was executed in partnership with Hola Media, which provided integration services, including installation, design, staff training, and support. The system has improved communication, reduced staff workload, and enhanced the guest experience, preparing the resort for future digital expansion.
Partners
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support
BHP Group Limited has announced the opening of applications for the 2026 cohort of its BHP Xplor accelerator program, which aims to transform the discovery of critical minerals. The program offers early-stage explorers up to USD $500,000 in equity-free funding, mentorship, and access to BHP’s global network. BHP Xplor has been successful in previous years, fostering partnerships and accelerating exploration projects. The program supports BHPs long-term growth by engaging with diverse exploration projects. Applications are open from September 8 to October 15, 2025.
Partners
"צעדים ראשונים": הטכנולוגיה הישראלית החדשנית שמנסה להידמות לחלב האם
Israeli company Wilk, based in Rehovot Science Park, is developing technology to produce various components found in breast milk, but not in formulas and breast milk substitutes. The company has already developed several processes for producing different components and has a partnership with Danone, the worlds second-largest manufacturer of breast milk substitutes. Wilk produces oligosaccharides, one of the most important components in breast milk, using lab cultures. The final product can be incorporated into breast milk substitutes, enriching them with these important components.
Investment
מנכ"לית וילק תסיים כהונה אחרי פחות מתשעה חודשים, כחלק מתוכנית התייעלות | כלכליסט
Vilk, a foodtech company that entered the stock market in 2021, has announced that its CEO, Avital Bek, will be leaving the company after less than nine months. The company, which has lost 87% of its value since its IPO and has failed to generate revenue, is undergoing a restructuring plan. The CFO, Moran Atar, will replace Bek. The company also reported that it is trying to find international collaborations in its field. Vilk entered the Tel Aviv Stock Exchange in February 2021 with a value of 291 million shekels, but is now valued at only 39 million shekels.
Management ChangesLayoffs
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
Biotechnology company Pluri Inc. has announced a strategic collaboration with Wilk Technologies Ltd., a developer of authentic, cell-cultured human and animal milk components. The partnership will leverage Pluri’s 3D cell-expansion technology and Wilk’s expertise in developing cultured human breast and animal milk products to create a unique medical food for the elderly. The global elderly nutrition market is valued at $25.2 billion and is estimated to reach $39.7 billion in less than 10 years. The collaboration aims to develop and scale Wilk’s innovative products to commercial readiness.
PartnersExpand
וילק התקדמה צעד משמעותי בתהליך של ייצור רכיבי שומן מתורבת
לאחר כישלון המיזוג עם ביו דבש: יצרנית החלב המתורבת וילק מחליפה מנכ"ל | כלכליסט
Cultured milk manufacturer, Vilak, has replaced its CEO following the failure of a merger with Bio Honey. Dr. Avital Beck has been appointed as the new CEO, replacing Tomer Aizen who had held the position for three years. Beck, a researcher with scientific knowledge and experience, was appointed to strengthen the scientific aspect of the company, in contrast to Aizen who was more focused on the business aspect. During Aizens tenure, Vilak signed an investment agreement with Danones venture capital arm, Terra owned by the parent company (Coca Cola Israel), and two other private investors, who invested a total of $3.5 million.
Management Changes
אחרי ההסכם לרכישת ביו דבש: וילק מפרסמת אזהרת עסק חי | כלכליסט
וילק טכנולוגיות, a company developing cultured milk components, has reported a business warning in its second-quarter reports. The company recently signed an agreement to acquire BioDvash, a honey production company. However, the company has been experiencing losses and negative cash flow, raising concerns about its ability to continue operating. Despite this, the company received a one-time grant of NIS 45,000 for its CEO. In April, the company secured an investment agreement with dairy giant Danone, Terra, and other private investors, totaling $3.5 million. The investors funds were received in May, amounting to NIS 12.4 million after deducting transaction costs. The agreement also stated that BioDvash will become a wholly-owned subsidiary of וילק טכנולוגיות in exchange for shares of the company.
Investment
למה המשקיעים נטשו את חברות הפודטק המבטיחות
The article discusses the struggles of three foodtech companies, Bio Honey, Vilak Technologies, and Stakeholder Foods, which have seen their stock prices plummet by about 90% from their peak two years ago. The companies, which are developing cultured food products, have yet to bring a commercial product to market and are rapidly depleting their cash reserves. Bio Honey and Vilak Technologies have both received warnings from their auditors about their ability to continue as a going concern. Stakeholder Foods, which was delisted from the Tel Aviv Stock Exchange and is now traded on NASDAQ, reported a loss of about $30 million last year and has only $6.5 million left in its coffers.
LayoffsInvestment
Steakholder Foods® To Participate in Danone-Led Strategic Investment Round in Cultured Milk Company Wilk Technologies
Steakholder Foods has announced its participation in a strategic investment round in Wilk Technologies. The company will purchase ordinary shares of Wilk worth $450,000, giving it a 2.5% stake in Wilk. Steakholder Foods aims to identify synergies with Wilk and explore strategic cooperation opportunities. The collaboration is seen as a step in expanding Steakholder Foods contribution to the Food-Tech ecosystem and optimizing its investment and holding structure. Wilk Technologies develops technologies for producing cultured human breast and animal milk and is publicly traded on the Tel Aviv Stock Exchange. Steakholder Foods is a deep-tech food company at the forefront of the cultured meat revolution, committed to sustainable food solutions.
Investment
Steakholder Foods® To Participate in Danone-Led Strategic Investment Round in Cultured Milk Company Wilk Technologies
Steakholder Foods has announced its participation in a strategic investment round in Wilk Technologies. The company will purchase ordinary shares of Wilk in the amount of $450,000, giving them a 2.5% stake in Wilk. Steakholder Foods aims to identify synergies with Wilk and engage in strategic cooperation surrounding its proprietary biology and printing technologies. The collaboration is seen as a step in expanding Steakholder Foods contribution to the Food-Tech ecosystem and optimizing its investment and holding structure. Wilk Technologies develops technologies for producing cultured human breast and animal milk and is publicly traded on the Tel Aviv Stock Exchange.
InvestmentPartners
In World First, Israeli FoodTech Company Wilk Presents First Cell-based Yogurt Produced with Cultured Milk Fat
Wilk, a bio-foodtech innovator, has developed the worlds first yogurt using cell-cultured milk fat. The hybrid product has been validated and presented to the public for tasting. This achievement demonstrates Wilks ability to produce functional cell-cultured milk components and brings them closer to their goal of producing authentic dairy products in a sustainable manner. The new product will also support Wilks efforts in developing human milk fat components for infant formula. Wilk operates at the intersection of biotech and foodtech and holds patents on laboratory production processes for creating real milk and milk components. They are publicly traded on the Tel Aviv Stock Exchange.
Customers
Wilk Launches Project to Produce World's First Yogurt Developed Using Cell-Cultured Milk Fat
Wilk has announced the launch of a new project to develop the first yogurt using cell-cultured milk fat. The yogurt will serve as proof of the viability of Wilks cell-based technology for minimizing the need to use animals in future dairy production. The project is expected to last approximately six months. Wilk is also working on developing cultured human milk components for infant formula.
Partners
Wilk Technologies edging closer to "genuinely" replicating breast milk, says VP
Wilk Technologies has developed an improved formula for its cell-based infant formula, aiming to replicate the benefits of breast milk. The company uses cell-cultured technology to isolate essential nutrients found in breast milk and incorporate them into their formula. While it acknowledges that breast milk is irreplaceable, the formula provides an optimal alternative for mothers who cannot or choose not to breastfeed. Wilk acquires human tissue cells from breast reduction surgeries and breast milk donations. The company operates in a lab setting, allowing for better control over the production process and avoiding the pasteurization of milk products. Wilk has secured a patent for its cell-cultured method and aims to revolutionize the dairy industry. Competitors in the market include 108Labs, biomilq, and TurtleTree.
CustomersInvestment
רכיבי החלב המתורבת של Wilk מאפשרים ייצור חלב מתורבת
Israeli company Wilk has made significant progress towards the production of cultured cow and human milk. Independent tests confirm that the milk produced by the company contains components identical to natural milk. Following the companys announcement to the stock exchange, the companys stock rose by 8%. Wilks milk is created from cultured mammary cells, meaning cells that have grown in a laboratory, without the need for live cows. Similarly, the company is developing human milk created from cells taken from women. The companys achievement is particularly significant considering its competitor, American company Biomilq, which is developing only cultured human milk, has not yet demonstrated the feasibility of its technology.
InvestmentExpand
Wilk Receives U.S. Patent for Cell-Based Milk Production Methods and Systems
Wilk, a company developing cell-based milk and milk components, has been awarded a patent approval for methods and systems for in-vitro milk production. The patent covers the companys industrial processes for producing both human and animal milk from milk-producing mammary cells. This technology enables the sustainable and cost-effective manufacture of real cultured milk while reducing greenhouse emissions and improving animal welfare. The patent provides long-term protection for Wilks intellectual property. The company is also submitting additional patent applications to increase milk production in a cultured system. Wilk aims to revolutionize the dairy industry by producing real milk without the need for animals and by developing specially cultured human breastmilk for infant health and development.
Investment
וילק מדווחת על תוצאות חיוביות
וילק, the worlds first company to present groundbreaking results in the field of breast milk, has announced significant breakthroughs and positive results in their research. The company has been conducting in-depth research on human breast milk in collaboration with the maternity department at Rabin Medical Center and the plastic surgery department at Ichilov Hospital. The research focused on the ability of human mammary cells grown in culture to produce breast milk fat. The company operates in two significant channels for producing breast milk, both through cell donation and directly from breast tissue. The ability to produce breast milk fat in cell culture is unique to these cells. The companys research has shown that the fat composition produced by these cells matches the natural composition found in breast milk.
Customers
BioMilk Rebrands as Wilk
Bio-FoodTech startup Wilk has officially unveiled its new brand and changed its name from BioMilk. The rebrand represents Wilks commitment to transforming the dairy industry through technologies that facilitate the sustainable cell-based production of high-quality human and animal milk. Wilk is at the forefront of developing solutions for long-term sustainable milk production. The company operates at the crossroads of Biotech and FoodTech and holds patents on laboratory production processes for replicating the milk of multiple mammals. Wilk is publicly traded on the Tel Aviv Stock Exchange.
Customers
שני יזמים הציעו לפרופ' ארגוב-ארגמן להקים חברה. תראו כמה היא שווה
The article is about Eran Gefen, the founder of G^Team, a strategic consulting company that helps businesses develop new growth engines. Gefen has experience working with CEOs and management of leading companies in Israel and around the world, including Coca Cola, Volt, Microsoft, Strauss, and Kimberly Clark. A previous company he founded was acquired by WIX. Gefen also runs the podcast Half an Hour of Inspiration and is the author of the book Creating Growth - Turning Business Creativity into a Work Plan.
None
Coca Cola Israel investing in cultured milk co Biomilk
The Central Bottling Company (Coca Cola Israel) has invested $2 million in Biomilk for research and development collaboration to expedite the arrival of lab-cultured milk products on the market. Biomilks share price has increased by 7.75%, and the companys market cap is NIS 223 million. Cultured milk is produced in the laboratory from protein cells, saving cows from suffering and reducing energy consumption in dairy farming. The Central Bottling Companys brand, Tara Dairy, will market the cultured milk products developed under the agreement. Biomilk will have exclusivity with the Central Bottling Company, which will purchase raw materials based on Biomilks cultured milk only.
InvestmentPartners
חלב אם במעבדה: החברה הישראלית עושה צעד גדול, והמניה מזנקת
ביומילק, a dairy company, experienced a 10% jump in its stock price after reporting progress in the development and production of lab-grown milk. The company is using cell samples to produce cow and human milk. The article discusses the advancements in lab-grown milk and the potential impact on the dairy industry. The event described in the article occurred on June 9, 2021.
Expand
ביומילק חוקרת אפשרות לייצור חלב מתורבת מנאקות
ביומילק, a company specializing in industrial processes for producing cultured milk, has started a new research project to produce camel milk. The company aims to isolate the cells that produce camel milk and grow them in a laboratory to create cultured milk. If successful, this research could be a breakthrough in the production of nutritious and healthy camel milk. Camel milk is known for its unique nutritional and health properties and is traditionally used to treat infectious and metabolic diseases. It is also used in certain cultures as a daily consumption milk and in the production of other dairy products.
Investment
https://www.jpost.com/jpost-tech/got-biomilk-lab-produced-milk-could-rival-the-real-stuff-665753
Israeli foodtech company BioMilk has announced its IPO, allowing investors to buy stock in the newly publicly trading company. BioMilk is in the race to develop lab-produced milk that could rival animal-based dairy products. They have also developed a technology for lab-produced cow milk and are seeking to develop an alternative type of breast milk. BioMilk aims to have lower hormone and antibiotic additives compared to traditional milk. The company is currently operating under a market cap of NIS 270 million value. The CEO of BioMilk expressed excitement about joining the Tel Aviv Stock Exchange (TASE) and bringing their products to the global market.
Public Trading
הנהלת חברת טכנולוגיית המזון ביומילק פתחה את המסחר לרגל רישום המניות בבורסה
BioMilk, a company that specializes in the development of technology for the production of cultured cows milk and mothers milk, has joined the Tel Aviv Stock Exchange. The company was established in 2018 and is part of the growing foodtech sector. The companys market value currently stands at about 270 million NIS. The companys shares were added to the stock exchange indices on April 5, 2021.
Public Trading
Israeli Firm BioMilk Is World's First Cultured Milk Company To Go Public
Israeli startup BioMilk, a food tech company that develops cultured cow and breast milk, has opened trading for its IPO on the Tel Aviv Stock Exchange. The company aims to produce milk that approximates the composition of commercial cow milk, free of synthetic or plant additives, and with lower hormones and antibiotics. BioMilk is also developing a lab-made replica for breast milk. In February, BioMilk completed a merger with Fantasy Network, a publicly-traded shell company. The current market cap of the company is NIS 270 million ($82.8 million). The IPO will allow BioMilk to enhance its development capabilities and bring its products to the global market. The company plans to expand its research team and develop its tech for dairy industry markets and pharmaceutical alternatives.
Public TradingManagement ChangesExpand
חברת הפוד-טק BioMilk נכנסת למדדי הבורסה, חודש לאחר שהחלה להיסחר
BioMilk, a food-tech company, has received recognition from the Tel Aviv Stock Exchange and investors after recently entering the stock market. The company, which develops cultured milk and colostrum, completed a merger with Fantasy Network and began trading on the Tel Aviv Stock Exchange under the name BioMilk (BMLK). The recognition from the stock exchange provides financial and scientific validation for BioMilk as a leading company in its field. The company has also filed a patent for methods to enhance milk production in cultured systems. This new process aims to increase the production of important milk components and improve control over their ratios, potentially having high industrial value.
Public TradingManagement Changes
לקראת המיזוג עם פנטזי נטוורק, ביו-מילק לקראת השלמת אבן דרך ראשונה
ביו-מילק, a company specializing in milk production, has received positive results from an independent laboratory test on its milk products. The test confirmed that the milk produced by ביו-מילק contains the key components necessary for milk production. The company plans to continue conducting further tests and aims to collaborate with the traditional dairy industry. The results indicate a technological breakthrough for ביו-מילק and its ability to produce real milk without the use of animals. The company intends to develop products based on milk from various animals and human milk. The findings suggest that the main milk components are present in the cell culture medium without the need for external introduction. The article does not mention any specific customers, partners, investment or acquisition details.
Customers
ממקס סטוק לחלב מתורבת: אבן צ'ארלס ניומן ישקיע 4 מיליון שקל בביו-מילק
ביו-מילק, חברת פיתוח חלב מתורבת, חתמה הסכם עם חברה פרטית בבעלות אבן צארלס ניומן וריקי סטיבן ניומן, במסגרתו יושקעו 4 מיליון שקל בחברה. ההשקעה תתבצע לאחר השלמת עסקת מיזוג בין ביו-מילק לפנטזי נטוורק. עם ההשקעה, המשקיעים יזכו לזכות ראשונים לקדם הנפקה של חברה בת של ביו-מילק באוסטרליה. ביו-מילק מפתחת תהליך תעשייתי לייצור חלב מתורבת וטכנולוגיה לייצור אוליגוסכרידים מחלב אם.
Investment
Lab-Cultured Breast Milk: Israeli Startup Races To Do It First
Israeli startup Bio Milk is developing technology to produce cultured cow and breast milk as an alternative to formula-feeding. The company aims to replicate the complex composition of natural breast milk and is in the final stage of becoming a publicly listed company. They have raised NIS 12 million ($3.7 million) from private investors and expect to receive an additional NIS 7 million ($2.18 million) in capital after going public. Bio Milk plans to release the first sample of cultured cows milk for testing in 2021 and cultured breast milk in 2022. The production of cultured breast milk could provide important health benefits and potentially have a lower environmental impact compared to formulas derived from cows milk.
InvestmentPublic Trading
הצלחה בניסוי של ביו-מילק, המתמזגת לפנטזי נטוורק, בדרך לייצור חלב מתורבת
Bio-Milk, a company merging with Fantasy Network, has successfully completed an experiment to increase the efficiency of milk production and fat separation. The results show that the cells responsible for milk production can extend the duration of fat separation and production without losing their ability to produce milk. This brings Bio-Milk closer to its goal of developing systems for commercial production of cultured milk and specific milk components. The company is also developing industrial processes for producing cultured milk without cow milking and for producing oligosaccharides from engineered microorganisms. The research results are encouraging and contribute to the companys plans for full development in 2021.
Expand
This Israeli firm intends to disrupt dairy industry by creating milk in labs
Bio Milk, a company focused on developing laboratory-cultured milk and meat substitutes, is planning to go public through a merger with Fantasy Network. The company aims to reduce the carbon footprint of the dairy industry and provide sustainable alternatives to cow milk. Bio Milk has patents on laboratory production processes and is capable of producing milk in laboratory settings. It is also working on replicating human milk under laboratory conditions. The companys competitors include Biomilq and TurtleTree Labs. Bio Milk intends to present its first cup of laboratory-produced milk in the third quarter of 2021 and plans to fund the process with 12 million shekels raised from private investors. The merger with Fantasy Network will result in Bio Milks owners owning 65%-75% of the merged company.
Public TradingInvestment
